Restoring erectile function by antioxidant therapy in diabetic rats

Area of Science:

• * Urology
• * Endocrinology
• * Oxidative Stress Research

Background:

• * Diabetes mellitus is associated with increased reactive oxygen species (ROS), leading to endothelial dysfunction, corpus cavernosum smooth muscle loss, and apoptosis.
• * These pathological changes contribute to erectile dysfunction in diabetic individuals.

Purpose of the Study:

• * To investigate the hypothesis that antioxidant therapy can restore erectile function in diabetic rats by inhibiting apoptosis.
• * To evaluate the efficacy of tempol (4-hydroxytetramethyl-piperidine-1-oxyl), an antioxidant, and insulin in improving erectile function.

Main Methods:

• * Forty male Sprague-Dawley rats were divided into five groups: healthy controls, diabetic, diabetic treated with tempol, diabetic treated with insulin, and diabetic treated with both tempol and insulin.
• * Erectile function was assessed by measuring intracavernous pressure.
• * Histological analyses (hematoxylin and eosin, Masson's trichrome, CD31 staining) were performed to evaluate smooth muscle, collagen, and endothelial cells. Apoptosis was assessed using TUNEL assay, and gene expression of ROS-related genes was analyzed.

Main Results:

• * Diabetic rats exhibited significantly decreased intracavernous pressure, smooth muscle area, and endothelial cell area compared to controls.
• * Treatment with tempol or insulin alone partially improved intracavernous pressure. Combined tempol and insulin restored smooth muscle area and significantly inhibited apoptosis.
• * While endothelial cell area was not restored, the combined therapy normalized apoptosis, suggesting a key mechanism for functional recovery.

Conclusions:

• * Combined administration of tempol and insulin effectively restored erectile function in diabetic rats.
• * The mechanism of action involves the inhibition of apoptosis in the corpus cavernosum.
• * This study provides the first evidence that tempol and insulin can reverse diabetes-induced erectile dysfunction by targeting apoptosis.